 WATERTOWN, Mass.--BUSINESS WIRE--Kala Pharmaceuticals, Inc. NASDAQ:KALA, a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report fourth quarter and full year 2020 financial results on Thursday, February 25, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET. The dial-in numbers to access t 